NW
Newron Pharmaceuticals S.p.A.
NWPHF · OTC
$20.00 +0.00% (+$0.00)
Piotroski F-Score Moderate
5/9Valuation
-
N/A P/E N/A
EV/EBITDA N/A
P/S N/A
Growth
-
N/A EPS growth N/A
Rev. growth N/A
FCF growth N/A
Profitability
-
N/A Gross margin N/A
Net margin N/A
Op. margin N/A
Quality
-
N/A ROIC N/A
ROE N/A
ROA N/A
Debt
-
N/A Debt/Equity N/A
Current ratio N/A
Int. coverage N/A
Stability
100 /100
Stable Beta 0.74x
Rev. volatility N/A
EPS volatility N/A
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o NWPHF
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Stefan Weber
Employees
22
Headquarters
Bresso
Prihajajoči dogodki
22 SEP.
Earnings
Upcoming earnings report